Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor-based morphometry study in de novo patients without cognitive impairment

Human Brain Mapping

Volumn 35, Issue 8, 2014, Pages 3932-3944

  Tessa, Carlo ^a   Lucetti, Claudio ^a   Giannelli, Marco ^b   Diciotti, Stefano ^c   Poletti, Michele ^d   Danti, Sabrina ^a   Baldacci, Filippo ^e   Vignali, Claudio ^a   Bonuccelli, Ubaldo ^e   Mascalchi, Mario ^c   Toschi, Nicola ^f,g,h  

^a Versilia Hospital   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d PATHOLOGY UNIT   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain atrophy; Cognitive status; De novo PD; Longitudinal study; TBM

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; LONGITUDINAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; STROOP TEST; SUBCORTEX; THALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE; ATROPHY; BRAIN; IMAGE PROCESSING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; ORGAN SIZE; PATHOLOGY; PSYCHOLOGY; THREE DIMENSIONAL IMAGING;

ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PARKINSON DISEASE;

EID: 84903947198     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22449     Document Type: Article

References (125)

1. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010): Mild cognitive impairment in Parkinson's disease: A multicenter pooled analysis. Neurology 75:1062-1069.
2. Albin RL, Young AB, Penney JB (1989): The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
3. Allen JS, Bruss J, Brown CK, Damasio H (2005): Normal neuroanatomical variation due to age: The major lobes and a parcellation of the temporal region. Neurobiol Aging 26:1245-1260.
4. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Text Revision. Washington, DC: American Psychiatric Publication, 943 p.
5. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G (2001): Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 22:45-46.
6. Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM (2010): Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 25:687-695.
7. Aron AR, Obeso J (2012): Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia? Mov Disord 27:339-340.
8. Ashburner J, Friston KJ (2003): Morphometry. In: Frackowiak RSJ, Friston KJ, Frith C, Dolan R, Friston KJ, Price CJ, Zeki S, Ashburner J, and Penny WD, editors. Human Brain Function, 2nd ed. New York: Academic Press. pp 707-724.
9. Avants BB, Yushkevich P, Pluta J, Minkoff D, Korczykowski M, Detre J, Gee JC (2010): The optimal template effect in hippocampus studies of diseased populations. Neuroimage 49:2457-2466.
10. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011): A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033-2044.
11. Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, Takahashi S, Fukuda H, Aoki M, Itoyama Y, Mori E, Takeda A (2012): Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: A 3-year longitudinal study. Brain 135:161-169.
12. Barzokis G, Beckson M, Lu PH, Nuecherterlein KH, Edwards N, Mintz J (2001): Age related changes in frontal and temporal lobes in men. Arch Gen Psychiatry 58:461-465.
13. Benton AL, Varney NR, Hamsher KD (1978): Visuospatial judgement. A clinical test. Arch Neurol 35:364-367.
14. Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007): A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254-259.
15. Borghammer P, Østergaard K, Cumming P, Gjedde A, Rodell A, Hall N, Chakravarty MM (2010): A deformation-based morphometry study of patients with early-stage Parkinson's disease. Eur J Neurol 17:314-320.
16. Bouchard TP, Malykhin N, Martin WR, Hanstock CC, Emery DJ, Fisher NJ, Camicioli RM (2008): Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 29:1027-1039.
17. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004): Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134.
18. Braak H, Del Tredici K (2008): Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916-1925.
19. Brenneis C, Seppi K, Schocke MF, Müller J, Luginger E, Bösch S, Löscher WN, Büchel C, Poewe W, Wenning GK (2003): Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 18:1132-1138.
20. Brooks D, Halliday GM (2009): Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull 78:97-104.
21. Brück A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO (2004): Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 75:1467-1469.
22. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT (2004): Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127:791-800.
23. Burton EJ, McKeith IG, Burn DJ, O'Brien JT (2005): Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20:1571-1576.
24. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2002a): A short version of the Stroop Test: normative data on Italian population. Nuova Rivista di Neurologia 12:111-115.
25. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2002b): Rey-Osterreith Complex Figure: Normative values in an Italian population sample. Neurol Sci 22:443-447.
26. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003): Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18:784-790.
27. Camicioli R, Gee M, Bouchard TP, Fisher NJ, Hanstock CC, Emery DJ, Martin WR (2009): Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. Parkinson Relat Disord 15:187-195.
28. Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C, Emery D, Martin WR (2011): Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia. Mov Disord 26:1443-1450.
29. Carlesimo GA, Caltagirone C, Gainotti G (1996): The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36:378-384.
30. Cerasa A, Messina D, Pugliese P, Morelli M, Lanza P, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A (2011): Increased prefrontal volume in PD with levodopa-induced dyskinesias: A voxel-based morphometry study. Mov Disord 26:807-812.
31. Cerasa A, Morelli M, Augimeri A, Salsone M, Novellino F, Gioia MC, Arabia G, Quattrone A (2013): Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. Parkinson Relat Disord 19:123-125.
32. Chung MK, Worsley KJ, Paus T, Cherif, C, Collins DL, Giedd JN, Rapoport J, Evans, AC (2001): A unified statistical approach to deformation-based morphometry. Neuroimage 14:595-606.
33. Compta Y, Pereira JB, Ríos J, Ibarretxe-Bilbao N, Junqué C, Bargalló N, Cámara A, Buongiorno M, Fernández M, Pont-Sunyer C, Martí MJ (2013): Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study. Parkinson Relat Disord doi: 10.1016/j.parkreldis.2013.03.009.
34. Courchesne E, Chisum H, Townsend J, Cowles A, Covington J, Egaas B, Harwood M, Hinds S, Press G (2000): Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 216:672-682.
35. Cummings JL, Benson F (1984): Subcortical dementia. Review of an emerging concept. Arch Neurol 41:874-879.
36. Dubois B, Slachevsky A, Litvan I, Pillon B (2000): The FAB: A Frontal Assessment Battery at bedside. Neurology 55:1621-1626.
37. Duncan J, Owen AM (2000): Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci 23:475-483.
38. Fahn S, Elton R, and the members of the Unified Parkinson's Disease rating Scale Development Committee (1987): Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, editors. Recent Developments in Parkinson's Disease. New York: MacMillan. pp 153-163.
39. Feldmann A, Illes Z, Kosztolanyi P, Illes E, Mike A, Kover F, Balas I, Kovacs N, Nagy F (2008): Morphometric changes of gray matter in Parkinson's disease with depression: A voxel-based morphometry study. Mov Disord 23:42-46.
40. Fichtenholtz HM, Dean HL, Dillon DG, Yamasaki H, McCarthy G, LaBar KS (2004): Emotion-attention network interactions during a visual oddball task. Brain Res Cogn Brain Res 20:67-80.
41. Folstein MF, Folstein SE, McHugh PR (1975): Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189-198.
42. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001): Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358:201-205.
43. Freeborough, PA, Fox NC (1998): Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr 22:838-843.
44. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, Ciceri E, Albanese A, Bruzzone MG (2009): White matter involvement in idiopathic Parkinson disease: A diffusion tensor imaging study. AJNR Am J Neuroradiol 30:1222-1226.
45. Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL (2002): Age-related total gray matter and white matter changes in normal adult brain: Part I. Volumetric MR imaging analysis. Am J Neuroradiol 23:1327-1333.
46. Gibb WR, Lees AJ (1988): The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
47. Grieve SM, Clark CR, Williams LM, Peduto AJ, Gordon E (2005): Preservation of limbic and paralimbic structures in aging. Hum Brain Mapp 25:391-401.
48. Guttman CRG, Jolesz FA, Kikinis R, Killiany RJ, Moss MB, Sandor T, Albert MS (1998): White matter changes with normal aging. Neurology 50:972-978.
49. Halliday GM (2009): Thalamic changes in Parkinson's disease. Parkinson Relat Disord 3(15 Suppl):S152-S155.
50. Hattori T, Orimo S, Aoki S, Ito K, Abe O, Amano A, Sato R, Sakai K, Mizusawa H (2012): Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 33:727-739.
51. Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW (2000): Time course of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Mov Disord 15:485-489.
52. Hauser RA, Holford NH (2002): Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Mov Disord 17:961-998.
53. Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000): Degeneration of the thalamic caudal intralaminar nuclei in Parkinson's disease. Ann Neurol 47:345-352.
54. Hoehn MM, Yahr MD (1967): Parkinsonism: onset, progression and mortality. Neurology 17:427-442.
55. Holthoff-Detto VA, Kessler J, Herholz K, Bonner H, Pietrzyk U, Wurker M, Ghaemi M, Wienhard K, Wagner R, Heiss WD (1997): Functional effects of striatal dysfunction in Parkinson disease. Arch Neurol 54:145-150.
56. Hosokai Y, Nishio Y, Hirayama K, Takeda A, Ishioka T, Sawada Y, Suzuki K, Itoyama Y, Takahashi S, Fukuda H, Mori E (2009): Distinct patterns of cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord 23:854-862.
57. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001): Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 108:571-580.
58. Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack Jr CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM (2009): Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects. Neuroimage 48:668-681.
59. Hua X, Gutman B, Boyle CP, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack Jr CR, Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, Thompson PM (2011): Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage 57:5-14.
60. Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D, Weiner MW, Thompson PM (2013): Alzheimer's Disease Neuroimaging Initiative. Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage 66:648-661.
61. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, Tolosa E (2010): Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81:650-657.
62. Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Bargallo N, Tolosa E (2012): Progression of cortical thinning in early Parkinson's disease. Mov Disord 27:1746-1753.
63. Jokinen P, Brück A, Aalto S, Forsback S, Parkkola R, Rinne JO (2009): Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinson Relat Disord 15:88-93.
64. Jubault T, Gagnon JF, Karama S, Ptito A, Lafontaine AL, Evans AC, Monchi O (2011): Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage 55:462-467.
65. Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Martí MJ, Pastor P, Gómez-Ansón B, Mercader JM (2005): Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 20:540-544.
66. Kamagata K, Motoi Y, Abe O, Shimoji K, Hori M, Nakanishi A, Sano T, Kuwatsuru R, Aoki S, Hattori N (2012): White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. Am J Neuroradiol 33:890-895.
67. Kaplan EF, Goodglass H, Wintraub S. 1983. The Boston Naming Test. Experimental Edition. Philadelphia, PA: Lea & Febiger.
68. Karagulle-Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P (2008): Altered diffusion in the frontal lobe in Parkinson disease. Am J Neuroradiol 29:501-505.
69. Kimura M, Minamimoto T, Matsumoto N, Hori Y (2004): Monitoring and switching of cortico-basal ganglia loop functions by the thalamo-striatal system. Neurosci Res 48:355-360.
70. Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, Christensen GE, Collins DL, Gee J, Hellier P, Song JH, Jenkinson M, Lepage C, Rueckert D, Thompson P, Vercauteren T, Woods RP, Mann JJ, Parsey RV (2009): Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46:786-802.
71. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003): Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol (Berl) 106:83-88.
72. Laakso MP, Partanen K, Riekkinen P (1995): Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46:678-681.
73. Lee JE, Cho KH, Kim M, Sohn YH, Lee PH (2012): The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction. J Neurol 259:469-473.
74. Lisanby SH, McDonald WM, Massey EW, Doraiswamy PM, Rozear M, Boyko OB, Krishnan KR, Nemeroff C (1993): Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm Suppl 40:13-21.
75. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012): Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349-356.
76. Lu PH, Apostolova LG, Green AE, Hwang K, Chung C, Thompson PM, Leow A, Lee G, Janvin CC, Larsen JP, Cummings JL, Aarsland D, Beyer MK (2009): A tensor-based morphometry study of patients with cognitive impairment and dementia in Parkinson's disease. Proceedings of the International Conference on Alzheimer's Disease 2009. Alzheimer Dementia: J Alzheimer Assoc 5:P60.
77. Lyoo CH, Ryu YH, Lee MS (2010): Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Mov Disord 25:496-499.
78. Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000): Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100:285-290.
79. McKeown MJ, Uthama A, Abugharbieh R, Palmer S, Lewis M, Huang X (2008): Shape (but not volume) changes in the thalami in Parkinson disease. BMC Neurol 8:8.
80. Meindl T, Teipel S, Elmouden R, Mueller S, Koch W, Dietrich O, Coates U, Reiser M, Glaser C (2010): Test-retest reproducibility of the default-mode network in healthy individuals. Hum Brain Mapp 3:237-246.
81. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012): Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 83:188-194.
82. Mendez MF, Adams NL, Lewandowski KS (1989): Neurobehavioral changes associated with caudate lesions. Neurology 39:349-354.
83. Meppelink AM, de Jong BM, Teune LK, van Laar T (2011): Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations. Mov Disord 26:142-147.
84. Michielse S, Coupland N, Camicioli R, Carter R, Seres P, Sabino J, Malykhin N (2010): Selective effects of aging on brain white matter microstructure: A diffusion tensor imaging tractography study. Neuroimage 5:1190-1201.
85. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005): Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224-229.
86. Nishio Y, Hirayama K, Takeda A, Hosokai Y, Ishioka T, Suzuki K, Itoyama Y, Takahashi S, Mori E (2010): Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 17:1090-1097.
87. Olanow WC, Stern MB, Sethi K (2009): The scientific and clinical basis for the treatment of Parkinson's disease. Neurology 72:S1-S136.
88. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G (1987): Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. J Neurol Sci 8:539-548.
89. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006): Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040-1049.
90. Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013): Prognosis of mild cognitive impairment in early Parkinson's disease: The Norwegian Park West Study. JAMA Neurol 25:1-7.
91. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junqué C, Bargallo N, Tolosa E (2012): Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 33:2521-2534.
92. Pitcher TL, Melzer TR, Macaskill MR, Graham CF, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ (2012): Reduced striatal volumes in Parkinson's disease: A magnetic resonance imaging study. Transl Neurodegener 1:17.
93. Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012): Mild cognitive impairments and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 83:601-606.
94. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB (2012): White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage 62:1675-1684.
95. Ramírez-Ruiz B, Martí MJ, Tolosa E, Bartrés-Faz D, Summerfield C, Salgado-Pineda P, Gómez-Ansón B, Junqué C (2005): Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 252:1345-1352.
96. Raven J, Raven JC, Court JH. 2003. Manual for Raven's Progressive Matrices and Vocabulary scales: Section 1. General overview. San Antonio, TX: Harcourt Assessment.
97. Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD (2004): Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: Replicability of regional differences in volume. Neurobiol Aging 25:377-396.
98. Richfield EK, Twyman R, Berent S (1987): Neurological syndrome following bilateral damage to the head of the caudate nuclei. Ann Neurol 22:768-771.
99. Riddle WR, Li R, Fitzpatrick JM, DonLevy SC, Dawant BM, Price RR (2004): Characterizing changes in MR images with color-coded Jacobians. Magn Reson Imaging 22:769-777.
100. Rüb U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, Braak H (2002): Parkinson's disease: The thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol Aging 23:245-254.
101. Salat DH, Greve DN, Pacheco JL, Quinn BT, Helmer KG, Buckner L, Fischl B (2009): Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage 44:1247-1258.
102. Salgado-Pineda P, Delaveau P, Falcon C, Blin O (2006): Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study. Br J Clin Pharmacol 62:546-551.
103. Sheik JI, Yesavage JA (1986): Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In: Clinical Gerontology. A Guide to Assessment and Intervention. New York: The Haworth Press. pp 165-173.
104. Sherman SM (2007): The thalamus is more than just a relay. Curr Opin Neurobiol 17:417-422.
105. Silton RL, Helter W, Towers DN, Engels AS, Spielberg JM, Edgar JC, Sass SM, Stewart JL, Sutton BP, Banich MT, Miller GA (2010): The time course of activity in dorsolateral prefrontal cortex and anterior cingulate cortex during top-down attentional control. Neuroimage 50:1292-1302.
106. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR (2007): Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly. Neurobiol Aging 28:1075-1087.
107. Smith SM, Nichols TE (2009): Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83-98.
108. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011): The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 26:289-96.
109. Spinnler H, Tognoni G (1987): Italian standardization and validation of neuropsychological tasks. Ital J Neurol Sci 6(Suppl 8):1-120.
110. Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA (2005): Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132:741-754.
111. Studholme C, Cardenas V, Schuff N, Rosen H, Miller B, Weiner M (2001): Detecting spatially consistent structural differences in Alzheimer's and fronto temporal dementia using deformation morphometry. Med Image Comput Computer Assist Interv (MICCAI) 41-48.
112. Summerfield C, Junqué C, Tolosa E, Salgado-Pineda P, Gómez-Ansón B, Martí MJ, Pastor P, Ramírez-Ruíz B, Mercader J (2005): Structural brain changes in Parkinson disease with dementia: A voxel-based morphometry study. Arch Neurol 62:281-285.
113. Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT (2005): Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64:861-865.
114. Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans AC, Toga AW (2000): Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404:190-193.
115. Tinaz S, Courtney MG, Stern CE (2011): Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 26:436-441.
116. Truong L, Brooks D, Amaral F, Henderson JM, Halliday GM (2009): Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia. Mov Disord 24:2128-2135.
117. Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, Gee JC (2010): N4ITK: improved N3 bias correction. IEEE Trans Med Imag 29:1310-1320.
118. Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM (2011): Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 68:1562-1568.
119. Westphal R, Simmons C, Bernanos M, Wood T, Crum W, Duricki D, Vernon A, Williams S, Cash D (2013): Pharmacological MRI and tensor-based morphometry in the 6-OHDA rat model of Parkinson's disease. Proceedings of the 21st International Society for Magnetic Resonance in Medicine, p 1043.
120. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007): Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130:1787-1798.
121. Van den Berge SA, Kevenaar JT, Sluijs JA, Hol EM (2012) Dementia in Parkinson's disease correlates with α-synuclein pathology but not with cortical astrogliosis. Parkinson Dis 420957.
122. Van der Werf YD, Witter MP, Groenewegen HJ (2002): The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 39:107-140.
123. Vernon AC, Modo M (2012): Do levodopa treatments modify the morphology of the parkinsonian brain? Mov Disord 27:166-167.
124. Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ (2005): Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64:545-547.
125. Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Martí MJ (2013): Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 84:875-882.